Sandu Pharmaceuticals fundamental analysis

SANDUPHQ

41.9

0.00 (0.00%)
Last updated on 6 May, 2026 | 15:28 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Sandu Pharmaceuticals Fundamentals

P/E Ratio

26.08

P/B Ratio

1.21

Div. Yield

2.39

Sector P/E

67.31

Sector P/B

3.59

Sec. Div. Yield

0.56

Sandu Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 26.08, compared to the sector average of 67.31. Its P/B Ratio stands at 1.21, while the sector’s is 3.59. In terms of returns, the stock offers a Dividend Yield of 2.39%, which is than the sector’s 0.56%.

Sandu Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Poor

  • quality_check
    Management

    Poor

On its scorecard, Sandu Pharmaceuticals reflects: Price – Attractive, Growth – Poor, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost